| 1 |
30598326 | Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease. | 2019 Feb |
4 |
| 2 |
30309894 | Thermodynamic destabilization and aggregation propensity as the mechanism behind the association of apoE3 mutants and lipoprotein glomerulopathy. | 2018 Dec |
1 |
| 3 |
28559318 | A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain-domain interactions. | 2017 Jun 13 |
3 |
| 4 |
27174096 | Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism. | 2016 Jul |
1 |
| 5 |
27586181 | Apolipoprotein Mimetic Peptides as Modulators of Lipoprotein Function. | 2016 |
2 |
| 6 |
24454848 | Human apolipoprotein e resequencing by proteomic analysis and its application to serotyping. | 2014 |
3 |
| 7 |
24573419 | Identification, expression and function of apolipoprotein E in annual fish Nothobranchius guentheri: implication for an aging marker. | 2014 Jun |
1 |
| 8 |
24766729 | Is formaldehyde the missing link in AD pathology? The differential aggregation of amyloid-beta with APOE isoforms in vitro. | 2014 |
2 |
| 9 |
24953047 | Compound heterozygotes for a novel mutation, apo E1 Nagoya (Arg142Ser) and Apo E2 (Arg158Cys), with severe type III hyperlipoproteinemia and familial hypercholesterolemia. | 2014 |
2 |
| 10 |
23503772 | The number of cysteine residues per mole in apolipoprotein E affects systematically synchronous neural interactions in women's healthy brains. | 2013 May |
1 |
| 11 |
24324968 | Novel natural structure corrector of ApoE4 for checking Alzheimer's disease: benefits from high throughput screening and molecular dynamics simulations. | 2013 |
3 |
| 12 |
22532692 | Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate. | 2012 Jul |
1 |
| 13 |
22615372 | Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer's disease. | 2012 Jun 5 |
1 |
| 14 |
21325775 | A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy. | 2011 |
1 |
| 15 |
21467726 | A novel mutation ApoE2 Kurashiki (R158P) in a patient with lipoprotein glomerulopathy. | 2011 |
2 |
| 16 |
21600318 | Local/bulk determinants of conformational stability of exchangeable apolipoproteins. | 2011 Sep |
1 |
| 17 |
19904741 | Structural differences between apolipoprotein E3 and E4 as measured by (19)F NMR. | 2010 Jan |
3 |
| 18 |
19823748 | Arginine-based PNA microarrays for APOE genotyping. | 2009 Nov |
1 |
| 19 |
15708851 | Examination of lipid-bound conformation of apolipoprotein E4 by pyrene excimer fluorescence. | 2005 Apr 15 |
1 |
| 20 |
15896001 | The receptor binding domain of apolipoprotein E is responsible for its antioxidant activity. | 2005 May 24 |
1 |
| 21 |
16291938 | Effect of domain interaction on apolipoprotein E levels in mouse brain. | 2005 Nov 16 |
5 |
| 22 |
15310270 | Apolipoprotein E structure and substrate and receptor-binding activities of triglyceride-rich human plasma lipoproteins in normo- and hypertriglyceridemia. | 2004 Jul |
4 |
| 23 |
12507771 | Microglial function in human APOE3 and APOE4 transgenic mice: altered arginine transport. | 2003 Jan |
5 |
| 24 |
12614323 | Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. | 2003 Mar |
1 |
| 25 |
11833049 | Interaction of endothelial cells and triglyceride-rich lipoproteins with apolipoprotein E (Arg-->Cys) from a patient with lipoprotein glomerulopathy. | 2002 Feb |
2 |
| 26 |
12076977 | Apolipoprotein-E allele-specific regulation of nitric oxide production. | 2002 May |
3 |
| 27 |
12392781 | APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress. | 2002 Sep-Oct |
2 |
| 28 |
12521230 | TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E. | 2002 Nov |
2 |
| 29 |
12575193 | [The paraoxonase Gln-Arg 192 polymorphism in patients with endogenous hypertriglyceridemia in Chinese population]. | 2002 Apr |
1 |
| 30 |
11181800 | Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy. | 2001 Mar |
3 |
| 31 |
11337906 | Characterization of an apolipoprotein E3 variant (Arg 145-->His) associated with mild hypertriglyceridemia. | 2001 Apr |
3 |
| 32 |
11369804 | Cationic domain 141-150 of apoE covalently linked to a class A amphipathic helix enhances atherogenic lipoprotein metabolism in vitro and in vivo. | 2001 Jun |
2 |
| 33 |
11500500 | New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E. | 2001 Oct 19 |
2 |
| 34 |
11553788 | Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E. | 2001 Sep 25 |
4 |
| 35 |
10644716 | Effect of arginine 172 on the binding of apolipoprotein E to the low density lipoprotein receptor. | 2000 Jan 28 |
4 |
| 36 |
10884290 | Apolipoprotein E;-low density lipoprotein receptor interaction. Influences of basic residue and amphipathic alpha-helix organization in the ligand. | 2000 Jul |
2 |
| 37 |
10911769 | Dietary fat clearance in type V hyperlipoproteinaemia secondary to a rare variant of human apolipoprotein E: the apolipoprotein E3 (Arg 136-->Ser) | 2000 Jun |
4 |
| 38 |
9920509 | Lipoprotein lipase greatly enhances the retention of lipoprotein(a) to endothelial cell-matrix. | 1999 Jan |
1 |
| 39 |
10432380 | A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy. | 1999 Aug |
2 |
| 40 |
14987560 | Potential role of apoE in structural plasticity in the nervous system; implications for disorders of the central nervous system. | 1998 Aug |
3 |
| 41 |
8995232 | Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease. | 1997 Jan 3 |
2 |
| 42 |
9057348 | Pattern of gradient of apolipoprotein E allele *4 frequencies in western Europe. | 1997 Apr |
6 |
| 43 |
9135136 | Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization. | 1997 Mar 17 |
1 |
| 44 |
9153287 | Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo. | 1997 May 15 |
1 |
| 45 |
9163848 | Abnormal lipid metabolism and renal disorders. | 1997 Mar |
1 |
| 46 |
9176854 | Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy. | 1997 May |
1 |
| 47 |
9360638 | Apolipoprotein E R112; R251G: a carboxy-terminal variant found in patients with hyperlipidemia and coronary heart disease. | 1997 Sep |
1 |
| 48 |
8635577 | Cerebrovascular amyloidosis in squirrel monkeys and rhesus monkeys: apolipoprotein E genotype. | 1996 Jan 29 |
3 |
| 49 |
8664327 | Characterization of a novel variant of apolipoprotein E, E2 Fukuoka (Arg-224 --> Gln) in a hyperlipidemic patient with xanthomatosis. | 1996 Jun 11 |
2 |
| 50 |
8682150 | Apolipoprotein E2 (Arg-136-->Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia. | 1996 Jan |
2 |